CQ Pharmaceutical Holding Co (SZSE:000950) Total Receivables: ¥42,436 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000950 CQ Pharmaceutical Holding Co Ltd SZSE:000950
79 GF Score
Price ¥5.34
GF Value ¥5.56
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is CQ Pharmaceutical Holding Co Total Receivables?

CQ Pharmaceutical Holding Co SZSE:000950 +2.50% 79 Total Receivables is ¥42,436 Mil as of Jun. 2026. GuruFocus rates SZSE:000950 with a GF Score™ of 79/100 and a GF Value™ of ¥5.56 (Fairly Valued). The stock has 8 warning signs investors should review.

CQ Pharmaceutical Holding Co's Total Receivables for the quarter that ended in Jun. 2026 was ¥42,436 Mil.

CQ Pharmaceutical Holding Co Total Receivables Related Terms

CQ Pharmaceutical Holding Co Total Receivables Historical Data

* Premium members only.

The historical data trend for CQ Pharmaceutical Holding Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CQ Pharmaceutical Holding Co Total Receivables Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,230.77 31,009.04 35,161.86 36,316.46 38,623.78

CQ Pharmaceutical Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39,553.27 40,377.17 38,623.78 42,431.94 42,435.61
SZSE:000950
79GF Score
CQ Pharmaceutical Holding Co Ltd SZSE:000950
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CQ Pharmaceutical Holding Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ¥42,436 Mil mean?
CQ Pharmaceutical Holding Co (SZSE:000950) has a Total Receivables of ¥42,436 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on CQ Pharmaceutical Holding Co and its competitors.
Is CQ Pharmaceutical Holding Co's Total Receivables too high?
CQ Pharmaceutical Holding Co's current Total Receivables is ¥42,436 Mil. Overall, CQ Pharmaceutical Holding Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CQ Pharmaceutical Holding Co's Total Receivables compare to MCK and COR?
CQ Pharmaceutical Holding Co's Total Receivables of ¥42,436 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Distribution company?
A good Total Receivables depends on the Medical Distribution industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on CQ Pharmaceutical Holding Co and its competitors. CQ Pharmaceutical Holding Co's current Total Receivables is ¥42,436 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CQ Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co (SZSE:000950) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.56, compared to a current price of ¥5.34 — trading 4% below its estimated fair value. The current Total Receivables is ¥42,436 Mil. CQ Pharmaceutical Holding Co's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For CQ Pharmaceutical Holding Co (SZSE:000950), the current Total Receivables is ¥42,436 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?

Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued. The current stock price of ¥5.34 is trading 4% below its estimated GF Value™ of ¥5.56. GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.

Key valuation signals for SZSE:000950:

  • Total Receivables: ¥42,436 Mil
  • GF Value™: ¥5.56 vs. price of ¥5.34 (4% below fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CQ Pharmaceutical Holding Co Business Description

Address 333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
79GF Score

Get the complete analysis for SZSE:000950

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.34
Price
¥5.56
GF Value